SIDE-effects caused by lung cancer medication approved for use in Japan have resulted in 124 deaths in less than six months, the nation's health ministry warned yesterday.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
